According to Todd R. Nelson, CEO of eBioscience, the company will be able to provide "more productive working environments" for both its administrative functions and its research and development lab facilities by having the two types of activities across the street from one another. The building that eBioscience will occupy was constructed in 2001 and is located off Science Center Drive, just west of Interstate 5 on a 2.75-acre site.
The building was purchased in May 2008 by Trammell Crow Co.'s Acquisition Funds team. purchased the building in May 2008. Tom Bak, senior managing director of Trammell Crow Co.'s Southern California Development and Investment Group in Irvine, notes that 10240 Science Center Dr. "was one of the few large blocks of space remaining in what has become San Diego's premier pharmaceutical and biotech hub." Bak adds that the flexible design of the building will enable eBioscience to customize its space to best fit its needs.
SVP Harry Lake III and principal Matt Hill with Trammell Crow Co. Acquisiton Funds team originated the investment for the fund and represented TCC in the transaction along with Bak and SVP Matt Cramer with Trammell Crow Co., along with SVP Jerry Keeney and senior associate Matt Nickels of the San Diego office of CB Richard Ellis. Additionally Keeney represented Alexandria Real Estate Equities and Trammell Crow Co. in the sale of 10240 Science Center Dr. in 2008.
Senior director Mickey Morera and associate director James Duncan of Cushman & Wakefield's San Diego office represented eBioscience in the transaction. Trammell Crow Co. is an independently operated subsidiary of CB Richard Ellis Group.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.